PDCD1 and neuroblastoma: Interestingly, BLZ-945 in combination with anti-PD-1 antibody showed synergy in improving the survival of TH-MYCN mouse model of neuroblastoma with noted greater T-cell activation and infiltration into the tumor microenvironment (56).